)
Visual24 Oct 2025
The rise of Alphabet
InMode (INMD) investor relations material
InMode Baird Global Healthcare Conference 2025 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Baird Global Healthcare Conference 2025 summary10 Sep, 2025
Market environment and operational adjustments
Aesthetic market slowdown began in summer 2023, driven by macroeconomic headwinds and softening demand.
Financing for capital equipment has tightened, with longer approval times and stricter credit requirements.
Implemented risk-sharing programs with leasing partners to expedite financing approvals.
Maintains a strong, debt-free balance sheet with significant cash reserves.
Down cycle in aesthetics is expected to last two to three years, with hopes for stabilization or recovery.
Product strategy and market penetration
Avoided lowering prices, instead expanding product offerings to become a one-stop shop, including new CO2 laser launches.
Combination treatments (e.g., Morpheus8 with CO2 laser) have driven product adoption.
Penetration among plastic surgeons is estimated at 25–30%, while dermatologists are at 5–7%, leaving significant room for growth.
Upgrade cycle and new product launches (e.g., Ignite RF, Quantum RF) are expected to drive further penetration.
Expansion into med spas and other physician categories is ongoing, leveraging broader device platforms.
Regulatory and geographic expansion
Pursuing FDA approval for dry eye indication in ophthalmology, with study start expected late 2024 or early 2025 and potential approval by end of 2026 or early 2027.
Early success in ophthalmology with IPL and RF combination, and a dedicated team is being established.
Women's health is a major growth area, with ongoing studies for additional indications and potential for a standalone business unit.
International growth has resumed, especially after leadership changes and direct operations in key markets like Germany and Japan.
China remains a long-term opportunity, with sales ongoing but awaiting broader product approvals.
Impact of financing risk-sharing on sales?
Strategy to increase derm penetration?
Outlook for Invision in ophthalmology?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next InMode earnings date
Q3 20255 Nov, 2025
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
A leading provider of minimally invasive treatments
InMode is a medical technology company that specializes in developing innovative solutions for minimally invasive cosmetic and medical procedures. The company was founded in 2008 and has since become a leading provider of minimally invasive aesthetic and medical treatments. Some of InMode’s competitors include Cutera, LivaNova, and TransMedics.
The business model
InMode's business model is based on developing and marketing cutting-edge medical technology solutions to meet the specific needs of physicians and patients around the world. The company's products and services include minimally invasive treatments for body contouring, skin rejuvenation, women's health, and more.
How InMode makes money
InMode generates revenue primarily through the sale of its medical technology products, as well as through ongoing customer support and service contracts. The company's revenue is also generated through its partnerships with other healthcare companies and organizations, as well as through collaborations with academic research institutions and other organizations.
Revolutionizing the field of medical aesthetics
InMode has developed and patented a range of advanced technologies that have revolutionized the field of medical aesthetics. One such technology is its BodyTite system, which uses radiofrequency energy to deliver heat to targeted areas of the body, tightening the skin and reducing fat without the need for surgery. The company has also developed minimally invasive treatments for vaginal rejuvenation, hair removal, and tattoo removal, among others.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage